indapamide has been researched along with acetazolamide in 18 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (16.67) | 18.7374 |
1990's | 1 (5.56) | 18.2507 |
2000's | 4 (22.22) | 29.6817 |
2010's | 10 (55.56) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cecchi, A; Scozzafava, A; Supuran, CT; Temperini, C | 3 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Čapkauskaitė, E; Gylytė, J; Kišonaitė, M; Matulis, D; Tumkevičius, S; Zubrienė, A | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Čapkauskaitė, E; Gražulis, S; Gylytė, J; Jogaitė, V; Kazokaitė, J; Kišonaitė, M; Manakova, E; Matulis, D; Michailovienė, V; Smirnov, A; Torresan, J; Tumkevičius, S; Zubrienė, A | 1 |
Chimirri, A; Damiano, FM; De Luca, L; Ferro, S; Gitto, R; Supuran, CT; Vullo, D | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
Čapkauskaitė, E; Gedgaudas, M; Kairys, V; Linkuvienė, V; Matulis, D; Paketurytė, V; Ruibys, V; Zakšauskas, A | 1 |
Greenberg, A | 1 |
Lettieri, JT; Portelli, ST | 1 |
Herbinger, W | 1 |
Baican, M; Coltau, M; Domuta, G; Hecht, A; Puscas, I | 1 |
1 review(s) available for indapamide and acetazolamide
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
17 other study(ies) available for indapamide and acetazolamide
Article | Year |
---|---|
Carbonic anhydrase inhibitors. Interaction of indapamide and related diuretics with 12 mammalian isozymes and X-ray crystallographic studies for the indapamide-isozyme II adduct.
Topics: Animals; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Computer Simulation; Crystallography, X-Ray; Humans; Indapamide; Isoenzymes; Mice; Models, Molecular; Molecular Structure | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Carbonic anhydrase inhibitors. Comparison of chlorthalidone and indapamide X-ray crystal structures in adducts with isozyme II: when three water molecules and the keto-enol tautomerism make the difference.
Topics: Carbonic Anhydrase Inhibitors; Catalytic Domain; Chlorthalidone; Crystallography, X-Ray; Indapamide; Isoenzymes; Models, Molecular; Stereoisomerism; Water | 2009 |
Carbonic anhydrase inhibitors. Comparison of chlorthalidone, indapamide, trichloromethiazide, and furosemide X-ray crystal structures in adducts with isozyme II, when several water molecules make the difference.
Topics: Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Chlorthalidone; Crystallography, X-Ray; Furosemide; Indapamide; Isoenzymes; Structure-Activity Relationship; Sulfonamides; Trichlormethiazide; Water | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Benzenesulfonamides with benzimidazole moieties as inhibitors of carbonic anhydrases I, II, VII, XII and XIII.
Topics: Benzenesulfonamides; Carbonic Anhydrase Inhibitors; Magnetic Resonance Spectroscopy; Mass Spectrometry; Spectrophotometry, Infrared; Sulfonamides | 2014 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Benzenesulfonamides with pyrimidine moiety as inhibitors of human carbonic anhydrases I, II, VI, VII, XII, and XIII.
Topics: Benzenesulfonamides; Binding Sites; Calorimetry; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Crystallography, X-Ray; Enzyme Activation; Humans; Isoenzymes; Kinetics; Protein Binding; Protein Structure, Tertiary; Pyrimidines; Recombinant Proteins; Structure-Activity Relationship; Sulfonamides | 2013 |
Structure-based screening for the discovery of new carbonic anhydrase VII inhibitors.
Topics: Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Drug Design; Humans; Molecular Docking Simulation; Structure-Activity Relationship | 2014 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Benzimidazole design, synthesis, and docking to build selective carbonic anhydrase VA inhibitors.
Topics: Benzimidazoles; Binding Sites; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Catalytic Domain; Drug Design; Humans; Isoenzymes; Molecular Docking Simulation; Structure-Activity Relationship | 2018 |
What's new in diuretic therapy.
Topics: Acetazolamide; Acid-Base Imbalance; Biological Transport; Diuretics; Drug Resistance; Ethacrynic Acid; Furosemide; Humans; Hydrochlorothiazide; Hyperkalemia; Hypernatremia; Hypokalemia; Hyponatremia; Indapamide; Kidney Tubules, Distal; Kidney Tubules, Proximal; Loop of Henle; Metolazone; Osmolar Concentration; Spironolactone; Triamterene; Vasopressins | 1986 |
Effects of competitive red blood cell binding and reduced hematocrit on the blood and plasma levels of [14C]Indapamide in the rat.
Topics: Acetazolamide; Animals; Binding, Competitive; Carbon Radioisotopes; Chlorthalidone; Diuretics; Erythrocytes; Hematocrit; Indapamide; Male; Rats; Rats, Inbred Strains | 1983 |
[Diuretics in the therapy of chronic cardiac insufficiency].
Topics: Acetazolamide; Amiloride; Diuretics; Drug Interactions; Ethacrynic Acid; Heart Failure; Humans; Indapamide; Metolazone; Risk; Spironolactone; Sulfonamides; Thiazoles; Ticrynafen; Triamterene | 1982 |
Vasodilatory effect of diuretics is dependent on inhibition of vascular smooth muscle carbonic anhydrase by a direct mechanism of action.
Topics: Acetazolamide; Aged; Amiloride; Animals; Blood Pressure; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Diuretics; Erythrocytes; Furosemide; Humans; Hydrochlorothiazide; Hydrogen-Ion Concentration; In Vitro Techniques; Indapamide; Middle Aged; Muscle, Smooth, Vascular; Rabbits; Triamterene; Vasodilation | 1999 |